Pages that link to "Q45731652"
Jump to navigation
Jump to search
The following pages link to Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis (Q45731652):
Displaying 34 items.
- Molecular and cell-based therapies for muscle degenerations: a road under construction (Q24568176) (← links)
- Inhibition of established collagen-induced arthritis with a tumour necrosis factor-alpha inhibitor expressed from a self-contained doxycycline regulated plasmid (Q24793412) (← links)
- Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients? (Q24796801) (← links)
- Gene therapy for arthritis--where do we stand? (Q24812824) (← links)
- The potential of adeno-associated viral vectors for gene delivery to muscle tissue (Q33902499) (← links)
- Early gestational gene transfer of IL-10 by systemic administration of lentiviral vector can prevent arthritis in a murine model (Q34169584) (← links)
- Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis (Q34735468) (← links)
- Clinical potential and challenges of using genetically modified cells for articular cartilage repair (Q35090336) (← links)
- Gene therapy in nonhuman primate models of human autoimmune disease. (Q35122173) (← links)
- Vectors for the treatment of autoimmune disease. (Q35122178) (← links)
- Perspectives on the use of gene therapy for chronic joint diseases (Q35151031) (← links)
- Gene transfer as a future therapy for rheumatoid arthritis (Q35164793) (← links)
- Gene therapy for autoimmune diseases: quo vadis? (Q35906093) (← links)
- Regulatable gene expression systems for gene therapy applications: progress and future challenges (Q36157542) (← links)
- Regulatable gene expression systems for gene therapy (Q36569912) (← links)
- scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints (Q36625357) (← links)
- The use of recombinant adeno-associated virus for skeletal gene therapy (Q36729692) (← links)
- Concepts in gene therapy for cartilage repair. (Q37099568) (← links)
- Preclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion gene (Q37134964) (← links)
- Gene therapy of the rheumatic diseases: 1998 to 2008. (Q37207021) (← links)
- In vivo gene regulation using tetracycline-regulatable systems (Q37460085) (← links)
- Gene therapy for rheumatoid arthritis: current status and future prospects (Q37952287) (← links)
- Gene and cell therapy based treatment strategies for inflammatory bowel diseases (Q37969759) (← links)
- Gene Therapy for Cartilage Repair (Q38526206) (← links)
- Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth factor I (IGF-I) overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis (Q39676689) (← links)
- Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes (Q40524596) (← links)
- Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. (Q40565579) (← links)
- Adeno-associated virus-mediated bone morphogenetic protein-4 gene therapy for in vivo bone formation. (Q45722268) (← links)
- Targeted gene therapy of autoimmune diseases: advances and prospects (Q45859107) (← links)
- Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. (Q45864096) (← links)
- IL-10 gene transfer attenuates P. gingivalis-induced inflammation. (Q50995771) (← links)
- IL-10 regulation of lupus in the NZM2410 murine model (Q80149194) (← links)
- Gene therapy for arthritis (Q80448411) (← links)
- Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system (Q84597809) (← links)